Search

Your search keyword '"Mizuno, Takashi"' showing total 1,427 results
Start Over Author "Mizuno, Takashi"
1,427 results on '"Mizuno, Takashi"'

3. Contributors

Author

Adam, René, primary, Akamatsu, Nobuhisa, additional, Allard, Marc-Antoine, additional, Ardiles, Victoria, additional, Arita, Junichi, additional, Bennink, Roelof J., additional, Chan, Albert, additional, Chirban, Ariana M., additional, Chun, Yun Shin, additional, Conrad, Claudius, additional, de Santibanes, Martin, additional, de Santibañes, Eduardo, additional, Ebata, Tomoki, additional, Erdmann, Joris I., additional, Halkic, Nermin, additional, Hasegawa, Kiyoshi, additional, Huang, Steven Y., additional, Ichida, Akihiko, additional, Imai, Katsunori, additional, Imamura, Hiroshi, additional, Ishizawa, Takeaki, additional, Kaneko, Junichi, additional, Kawaguchi, Shohei, additional, Kawaguchi, Yoshikuni, additional, Kawakatsu, Shoji, additional, Keith, Au Kin Pan, additional, Kishi, Yoji, additional, Kobayashi, Kosuke, additional, Kobayashi, Yuta, additional, Kogure, Masaharu, additional, Kokudo, Takashi, additional, Kokudo, Norihiro, additional, Matsuki, Ryota, additional, Mihara, Yuichiro, additional, Mizuno, Takashi, additional, Momose, Hirokazu, additional, Nagata, Rihito, additional, Olthof, Pim B., additional, Onoe, Shunsuke, additional, Saiura, Akio, additional, Sakamoto, Yoshihiro, additional, Seyama, Yasuji, additional, Shindoh, Junichi, additional, Shirata, Chikara, additional, Suzuki, Yutaka, additional, Takahashi, Atsushi, additional, Takeda, Yoshinori, additional, Takemura, Nobuyuki, additional, Tateishi, Ryosuke, additional, van Gulik, Thomas M., additional, Vauthey, Jean-Nicolas, additional, and Vega, Eduardo A., additional

Published
2024
Full Text
View/download PDF

5. Intraductal papillary neoplasms of the bile ducts: a comparative study of a rare disease in Europe and Nagoya, Japan

Author

Lluís, Núria, Onoe, Shunsuke, Serradilla-Martín, Mario, Achalandabaso, Mar, Mizuno, Takashi, Jehaes, François, Dasari, Bobby V.M., Mambrilla-Herrero, Sara, Sparrelid, Ernesto, Balakrishnan, Anita, Hoogwater, Frederik J.H., Amaral, María J., Andersson, Bodil, Berrevoet, Frederik, Doussot, Alexandre, López-López, Víctor, Detry, Olivier, Pozo, Carlos Domingo-del, Machairas, Nikolaos, Pekli, Damján, Alcázar-López, Cándido F., Asbun, Horacio, Björnsson, Bergthor, Christophides, Thalis, Díez-Caballero, Alberto, Francart, David, Noel, Colin B., Sousa-Silva, Donzília, Toledo-Martínez, Enrique, Tzimas, George N., Yaqub, Sheraz, Yamaguchi, Junpei, Dokmak, Safi, Prieto-Calvo, Mikel, D'Souza, Melroy A., Spiers, Harry V.M., van den Heuvel, Marius C., Charco, Ramón, Lesurtel, Mickaël, Ebata, Tomoki, and Ramia, José M.

Published
2024
Full Text
View/download PDF

17. Evaluation of 4D Flow MRI‐Derived Relative Residence Time as a Marker for Cirrhosis Associated Portal Vein Thrombosis.

Author

Hyodo, Ryota, Takehara, Yasuo, Ishizu, Yoji, Nishida, Kazuki, Mizuno, Takashi, Ichikawa, Kazushige, Horiguchi, Ryota, Kurata, Nobuhiko, Ogura, Yasuhiro, Yokoyama, Shinya, Naganawa, Shinji, Jin, Ning, and Ichiba, Yoshito

Subjects
PLATELET count, STAGNATION flow, PORTAL vein, KIDNEY function tests, FLOW velocity
Abstract

Background: Portal vein thrombosis (PVT) is thought to arise from stagnant blood flow, yet conclusive evidence is lacking. Relative residence time (RRT) assessed using 4D Flow MRI may offer insight into portal flow stagnation. Purpose: To explore the relationship between RRT values and the presence of PVT in cirrhotic participants. Study Type: Prospective. Population: Forty‐eight participants with liver cirrhosis (27 males, median age 67 years [IQR: 57–73]) and 20 healthy control participants (12 males, median age 45 years [IQR: 40–54]). Field Strength/Sequence: 3 T/4D Flow MRI. Assessment: Laboratory (liver and kidney function test results and platelet count) and clinical data (presence of tumors and other imaging findings), and portal hemodynamics derived from 4D Flow MRI (spatiotemporally averaged RRT [RRT‐mean], flow velocity, and flow rate) were analyzed. Statistical Tests: We used multivariable logistic regression, adjusted by selected covariates through the Lasso method, to explore whether RRT‐mean is an independent risk factor for PVT. The area under the ROC curve (AUC) was also calculated to assess the model's discriminative ability. P < 0.05 indicated statistical significance. Results: The liver cirrhosis group consisted of 16 participants with PVT and 32 without PVT. Higher RRT‐mean values (odds ratio [OR] 11.4 [95% CI: 2.19, 118]) and lower platelet count (OR 0.98 per 1000 μL [95% CI: 0.96, 0.99]) were independent risk factors for PVT. The incorporation of RRT‐mean (AUC, 0.77) alongside platelet count (AUC, 0.75) resulted in an AUC of 0.84. When including healthy control participants, RRT‐mean had an adjusted OR of 12.4 and the AUC of the combined model (RRT‐mean and platelet count) was 0.90. Data Conclusion: Prolonged RRT values and low platelet count were significantly associated with the presence of PVT in cirrhotic participants. RRT values derived from 4D Flow MRI may have potential clinical relevance in the management of PVT. Evidence Level: 2 Technical Efficacy: Stage 2 [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

19. Clinical and medical economic value of screening colonoscopy before laparoscopic cholecystectomy

Author

Igami, Tsuyoshi, primary, Nakamura, Masanao, additional, Ishikawa, Takuya, additional, Yamamura, Takeshi, additional, Yamao, Kentaro, additional, Maeda, Keiko, additional, Mizutani, Yasuyuki, additional, Sawada, Tsunaki, additional, Yokoyama, Yukihiro, additional, Mizuno, Takashi, additional, Yamaguchi, Junpei, additional, Onoe, Shunsuke, additional, Sunagawa, Masaki, additional, Watanabe, Nobuyuki, additional, Baba, Taisuke, additional, Kawakatsu, Shoji, additional, Kawashima, Hiroki, additional, and Ebata, Tomoki, additional

Published
2024
Full Text
View/download PDF

21. Ecological and genomic profiling of anaerobic methane-oxidizing archaea in a deep granitic environment

Author

Ino, Kohei, Hernsdorf, Alex W, Konno, Uta, Kouduka, Mariko, Yanagawa, Katsunori, Kato, Shingo, Sunamura, Michinari, Hirota, Akinari, Togo, Yoko S, Ito, Kazumasa, Fukuda, Akari, Iwatsuki, Teruki, Mizuno, Takashi, Komatsu, Daisuke D, Tsunogai, Urumu, Ishimura, Toyoho, Amano, Yuki, Thomas, Brian C, Banfield, Jillian F, and Suzuki, Yohey

Subjects
Microbiology, Biological Sciences, Human Genome, Genetics, Anaerobiosis, Environment, Genomics, Groundwater, Methane, Methanosarcinales, Nitrates, Oxidation-Reduction, Phylogeny, Silicon Dioxide, Sulfates, Environmental Sciences, Technology, Biological sciences, Environmental sciences
Abstract

Recent single-gene-based surveys of deep continental aquifers demonstrated the widespread occurrence of archaea related to Candidatus Methanoperedens nitroreducens (ANME-2d) known to mediate anaerobic oxidation of methane (AOM). However, it is unclear whether ANME-2d mediates AOM in the deep continental biosphere. In this study, we found the dominance of ANME-2d in groundwater enriched in sulfate and methane from a 300-m deep underground borehole in granitic rock. A near-complete genome of one representative species of the ANME-2d obtained from the underground borehole has most of functional genes required for AOM and assimilatory sulfate reduction. The genome of the subsurface ANME-2d is different from those of other members of ANME-2d by lacking functional genes encoding nitrate and nitrite reductases and multiheme cytochromes. In addition, the subsurface ANME-2d genome contains a membrane-bound NiFe hydrogenase gene putatively involved in respiratory H2 oxidation, which is different from those of other methanotrophic archaea. Short-term incubation of microbial cells collected from the granitic groundwater with 13C-labeled methane also demonstrates that AOM is linked to microbial sulfate reduction. Given the prominence of granitic continental crust and sulfate and methane in terrestrial subsurface fluids, we conclude that AOM may be widespread in the deep continental biosphere.

Published
2018

23. Risk factors for recurrent biliary obstruction following suprapapillary placement of a plastic stent as preoperative biliary drainage for perihilar biliary malignancy.

Author

Kataoka, Kunio, Ishikawa, Takuya, Yamao, Kentaro, Mizutani, Yasuyuki, Iida, Tadashi, Uetsuki, Kota, Onoe, Shunsuke, Mizuno, Takashi, Ebata, Tomoki, and Kawashima, Hiroki

Abstract

Background/Purpose: The usefulness of endoscopic biliary stenting by deploying a plastic stent suprapapillary, called inside‐stent (IS) placement, as preoperative biliary drainage (PBD) for perihilar biliary malignancy (PHBM) has been demonstrated. This study investigated risk factors for recurrent biliary obstruction (RBO) after IS placement. Methods: Consecutive patients with potentially resectable PHBM treated with IS placement as PBD between 2017 and 2023 at Nagoya University Hospital were retrospectively reviewed. Results: A total of 157 patients were included, with RBO occurring in 34 (22%) patients. The non‐RBO rates were 83% at 30 days, 77% at 60 days, and 57% at 90 days. The most common cause of RBO was stent occlusion (n = 14), followed by segmental cholangitis (n = 12) and stent migration (n = 8). Stent migration and occlusion occurred more frequently within and after 1 week post‐stenting, respectively. In multivariate analysis, biliary infection before IS was the sole risk factor for RBO, with a hazard ratio of 2.404 (95% confidence interval 1.163–4.972; p =.018). This risk was reduced by temporary endoscopic nasobiliary drainage prior to definitive IS placement. Conclusions: Biliary infection before IS was identified as an independent risk factor for RBO in patients with PHBM with IS as PBD. Clinical Trial Register: Clinical trial registration number: UMIN000025631. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

34. Impact of skeletal muscle mass on the prognosis of patients undergoing neoadjuvant chemotherapy for resectable or borderline resectable pancreatic cancer

Author

Nakajima, Hiroki, Yamaguchi, Junpei, Takami, Hideki, Hayashi, Masamichi, Kodera, Yasuhiro, Nishida, Yoshihiro, Watanabe, Nobuyuki, Onoe, Shunsuke, Mizuno, Takashi, Yokoyama, Yukihiro, Ebata, Tomoki, Nakajima, Hiroki, Yamaguchi, Junpei, Takami, Hideki, Hayashi, Masamichi, Kodera, Yasuhiro, Nishida, Yoshihiro, Watanabe, Nobuyuki, Onoe, Shunsuke, Mizuno, Takashi, Yokoyama, Yukihiro, and Ebata, Tomoki

Abstract

Background: Neoadjuvant chemotherapy is a common therapeutic procedure for patients with pancreatic cancer. This study aimed to investigate the association between the total psoas area (TPA) and prognosis in patients undergoing neoadjuvant chemotherapy for resectable or borderline resectable pancreatic cancer. Study design: This retrospective study included patients who underwent neoadjuvant chemotherapy for pancreatic cancer. TPA was measured at the level of the L3 vertebra using computed tomography. The patients were divided into low-TPA and normal-TPA groups. These dichotomizations were separately performed in patients with resectable and those with borderline resectable pancreatic cancer. Results: In total, 44 patients had resectable pancreatic cancer and 71 patients had borderline resectable pancreatic cancer. Overall survival among patients with resectable pancreatic cancer did not differ between the normal- and low-TPA groups (median, 19.8 vs. 21.8 months, p = 0.447), whereas among patients with borderline resectable pancreatic cancer, the low-TPA group had shorter overall survival than the normal-TPA group (median, 21.8 vs. 32.9 months, p = 0.006). Among patients with borderline resectable pancreatic cancer, the low-TPA group was predictive of poor overall survival (adjusted hazard ratio, 2.57, p = 0.037). Conclusion: Low TPA is a risk factor of poor survival in patients undergoing neoadjuvant chemotherapy for borderline resectable pancreatic cancer. TPA evaluation could potentially suggest the treatment strategy in this disease.

Published
2024

35. Early Prediction of a Serious Postoperative Course in Perihilar Cholangiocarcinoma

Author

Kawakatsu, Shoji, Yamaguchi, Junpei, Mizuno, Takashi, Watanabe, Nobuyuki, Onoe, Shunsuke, Igami, Tsuyoshi, Yokoyama, Yukihiro, Uehara, Kay, Nagino, Masato, Matsuo, Keitaro, Ebata, Tomoki, Kawakatsu, Shoji, Yamaguchi, Junpei, Mizuno, Takashi, Watanabe, Nobuyuki, Onoe, Shunsuke, Igami, Tsuyoshi, Yokoyama, Yukihiro, Uehara, Kay, Nagino, Masato, Matsuo, Keitaro, and Ebata, Tomoki

Abstract

Objective: The aim of this study was to visualize the postoperative clinical course using the comprehensive complication index (CCI) and to propose an early alarming sign for subsequent serious outcomes in perihilar cholangiocarcinoma. Background: Surgery for this disease carries a high risk of morbidity and mortality. The developmental course of the overall morbidity burden and its clinical utility are unknown. Methods: Patients who underwent major hepatectomy for perihilar cholan-giocarcinoma between 2010 and 2019 were reviewed retrospectively. All postoperative complications were evaluated according to the Clavien-Dindo classification (CDC), and the CCI was calculated on a daily basis until postoperative day 14 to construct an accumulating graph as a trajectory. Group-based trajectory modeling was conducted to categorize the trajectory into clinically distinct patterns and the predictive power of early CCI for a subsequent serious course was assessed. Results: A total of 4230 complications occurred in the 484 study patients (CDC grade I, n = 27; II, n = 132; IlIa, n = 290; IIIb, n = 4; IVa, n = 21; IVb, n = 1; and V, n = 9). The trajectory was categorized into 3 patterns: mild (n = 209), moderate (n = 235), and severe (n = 40) morbidity courses. The 90-day mortality rate significantly differed among the courses: 0%, 0.9%, and 17.5%, respectively (P<0.001). The cutoff values of the CCI on postoperative days 1, 4, and 7 for predicting a severe morbidity course were 15.0, 28.5, and 40.6 with areas under the curves of 0.780, 0.924, and 0.984, respectively. Conclusions: The CCI could depict the chronological increase in the overall morbidity burden, categorized into 3 patterns. Early CCI potentially predicted sequential progression to serious outcomes.

Published
2024

36. Efficacy of Extended Modification in Left Hemihepatectomy for Advanced Perihilar Cholangiocarcinoma

Author

Otsuka, Shimpei, Mizuno, Takashi, Yamaguchi, Junpei, Onoe, Shunsuke, Watanabe, Nobuyuki, Shimoyama, Yoshie, Igami, Tsuyoshi, Uehara, Kay, Yokoyama, Yukihiro, Nagino, Masato, Ebata, Tomoki, Otsuka, Shimpei, Mizuno, Takashi, Yamaguchi, Junpei, Onoe, Shunsuke, Watanabe, Nobuyuki, Shimoyama, Yoshie, Igami, Tsuyoshi, Uehara, Kay, Yokoyama, Yukihiro, Nagino, Masato, and Ebata, Tomoki

Abstract

Objective: The aim of this study was to verify the prognostic impact of the tumor exposure at the liver transection margin (LTM) in left-sided perihilar cholangiocarcinoma and the impact of middle hepatic vein (MHV) resection on this exposure. Background: In perihilar cholangiocarcinoma, tumors are unexpectedly exposed at the LTM during left hemihepatectomy (LH). Methods: Patients who underwent LH for perihilar cholangiocarcinoma during 2002 to 2018 were retrospectively evaluated. LH was classified into conventional and extended types, which preserved and resected the MHVs, respectively. Positive LTM was defined as the involvement of invasive carcinoma at the liver transection plane and/or the adjacent Glissonean pedicle exposed. The clinicopathologic features and survival outcomes were compared between procedures. Results: Among 236 patients, conventional and extended LHs were performed in 198 and 38 patients, respectively. The LTM was positive in 31 (13%) patients, with an incidence of 14% versus 8% (P = 0.432) and 24% versus 0% in advanced tumors (P = 0.011). Tumor size ≥ 18 mm (P = 0.041), portal vein invasion (P = 0.009), and conventional LH (P = 0.028) independently predicted positive LTM. In patients with negative LTM, the survival was comparable between the two groups: 60.4% versus 59.2% at 3 years (P = 0.206), which surpassed 17.7% for those with positive LTM in the conventional group (P < 0.001). Multivariable analysis demonstrated that LTM status was an independent prognostic factor (P = 0.009) along with ductal margin status (P = 0.030). Conclusions: The LTM status is an important prognostic factor in perihilar cholangiocarcinoma. Extended LH reduced the risk of tumor exposure at the LTM with a subsequent improvement in the survival, particularly in advanced tumors.

Published
2024

37. Which modality is better to diagnose high-grade transformation in retroperitoneal liposarcoma? Comparison of computed tomography, positron emission tomography, and magnetic resonance imaging

Author

Nakashima, Yu, Yokoyama, Yukihiro, Ogawa, Hiroshi, Sakakibara, Ayako, Sunagawa, Masaki, Nishida, Yoshihiro, Mizuno, Takashi, Yamaguchi, Junpei, Onoe, Shunsuke, Watanabe, Nobuyuki, Kawakatsu, Shoji, Igami, Tsuyoshi, Ebata, Tomoki, Nakashima, Yu, Yokoyama, Yukihiro, Ogawa, Hiroshi, Sakakibara, Ayako, Sunagawa, Masaki, Nishida, Yoshihiro, Mizuno, Takashi, Yamaguchi, Junpei, Onoe, Shunsuke, Watanabe, Nobuyuki, Kawakatsu, Shoji, Igami, Tsuyoshi, and Ebata, Tomoki

Abstract

Background: Survival in patients with retroperitoneal liposarcoma (RPLS) depends on the surgical management of the dedifferentiated foci. The present study investigated the diagnostic yield of contrast-enhanced CT, 18F-fluorodeoxyglucose positron emission tomography (PET), and diffusion-weighted MRI in terms of dedifferentiated foci within the RPLS. Methods: Patients treated with primary or recurrent RPLS who underwent the above imaging between January 2010 and December 2021 were retrospectively reviewed. The diagnostic accuracy of the three modalities for histologic subtype of dedifferentiated liposarcoma (DDLS) and French Federation of Cancer Center (FNCLCC) grade 2/3 were compared using receiver operating characteristic curves and areas under the curves (AUCs). Results: The cohort involved 32 patients with 53 tumors; 30 of which exhibited DDLS and 31 of which did FNCLCC grades 2/3. The optimal thresholds for predicting DDLS were mean CT value of 31 Hounsfield Unit (HU) (AUC = 0.880, 95% CI 0.775–0.984; p < 0.001), maximum standardized uptake value (SUVmax) of 2.9 (AUC = 0.865 95% CI 0.792–0.980; p < 0.001), while MRI failed to differentiate DDLS. The cutoff values for distinguishing FNCLCC grades 1 and 2/3 were a mean CT value of 24 HU (AUC = 0.858, 95% CI 0.731–0.985; p < 0.001) and SUVmax of 2.9 (AUC = 0.885, 95% CI 0.792–0.978; p < 0.001). MRI had no sufficient power to separate these grades. Conclusions: Contrast-enhanced CT and PET were useful for predicting DDLS and FNCLCC grade 2/3, while MRI was inferior to these two modalities.

Published
2024

38. Two-step arterial reconstruction technique for en bloc resection of a large retroperitoneal liposarcoma involving the common iliac artery

Author

Sunagawa, Masaki, Yokoyama, Yukihiro, Banno, Hiroshi, Sugimoto, Masayuki, Mizuno, Takashi, Yamaguchi, Junpei, Onoe, Shunsuke, Watanabe, Nobuyuki, Kawakatsu, Shoji, Ebata, Tomoki, Sunagawa, Masaki, Yokoyama, Yukihiro, Banno, Hiroshi, Sugimoto, Masayuki, Mizuno, Takashi, Yamaguchi, Junpei, Onoe, Shunsuke, Watanabe, Nobuyuki, Kawakatsu, Shoji, and Ebata, Tomoki

Abstract

Retroperitoneal liposarcoma (RPLS) is a rare but challenging neoplasm, which is frequently associated with iliac vessel invasion. We describe how we used a two-step arterial reconstruction technique to perform en bloc resection of a large RPLS involving the iliac arteries in three patients. A temporal long in situ graft bypass was established using a prosthetic vascular graft during dissection of the tumor. This bypass provided an unobscured surgical field, while maintaining blood flow in the lower limb during the operation. After removal of the tumor and washing out the abdominal cavity, the new prosthetic vascular graft of a suitable length was placed. No graft-related complications, including vascular graft infection or graft occlusion, occurred during the follow-up period. This novel technique appears to provide a safe and effective way to remove large RPLSs involving the retroperitoneal major vessels., Published: 20 April 2023

Published
2024

43. CTFS-ForestGEO: a worldwide network monitoring forests in an era of global change

Author

Anderson-Teixeira, Kristina J, Davies, Stuart J, Bennett, Amy C, Gonzalez-Akre, Erika B, Muller-Landau, Helene C, Joseph Wright, S., Abu Salim, Kamariah, Almeyda Zambrano, Angélica M, Alonso, Alfonso, Baltzer, Jennifer L, Basset, Yves, Bourg, Norman A, Broadbent, Eben N, Brockelman, Warren Y, Bunyavejchewin, Sarayudh, Burslem, David F. R. P, Butt, Nathalie, Cao, Min, Cardenas, Dairon, Chuyong, George B, Clay, Keith, Cordell, Susan, Dattaraja, Handanakere S, Deng, Xiaobao, Detto, Matteo, Du, Xiaojun, Duque, Alvaro, Erikson, David L, Ewango, Corneille E.N., Fischer, Gunter A, Fletcher, Christine, Foster, Robin B, Giardina, Christian P, Gilbert, Gregory S, Gunatilleke, Nimal, Gunatilleke, Savitri, Hao, Zhanqing, Hargrove, William W, Hart, Terese B, Hau, Billy C.H., He, Fangliang, Hoffman, Forrest M, Howe, Robert W, Hubbell, Stephen P, Inman-Narahari, Faith M, Jansen, Patrick A, Jiang, Mingxi, Johnson, Daniel J, Kanzaki, Mamoru, Kassim, Abdul Rahman, Kenfack, David, Kibet, Staline, Kinnaird, Margaret F, Korte, Lisa, Kral, Kamil, Kumar, Jitendra, Larson, Andrew J, Li, Yide, Li, Xiankun, Liu, Shirong, Lum, Shawn K.Y., Lutz, James A, Ma, Keping, Maddalena, Damian M, Makana, Jean-Remy, Malhi, Yadvinder, Marthews, Toby, Mat Serudin, Rafizah, McMahon, Sean M, McShea, William J, Memiaghe, Hervé R, Mi, Xiangcheng, Mizuno, Takashi, Morecroft, Michael, Myers, Jonathan A, Novotny, Vojtech, de Oliveira, Alexandre A, Ong, Perry S, Orwig, David A, Ostertag, Rebecca, den Ouden, Jan, Parker, Geoffrey G, Phillips, Richard P, Sack, Lawren, Sainge, Moses N, Sang, Weiguo, Sri-ngernyuang, Kriangsak, Sukumar, Raman, Sun, I-Fang, Sungpalee, Witchaphart, Suresh, Hebbalalu Sathyanarayana, Tan, Sylvester, Thomas, Sean C, Thomas, Duncan W, Thompson, Jill, Turner, Benjamin L, Uriarte, Maria, Valencia, Renato, Vallejo, Marta I, and Vicentini, Alberto

Published
2015

49. FOENIX-CCA4: A phase 2 study of futibatinib 20 mg and 16 mg in patients with advanced cholangiocarcinoma (CCA) and fibroblast growth factor receptor 2 (FGFR2) fusions/rearrangements.

Author

Macarulla, Teresa, primary, Mizuno, Takashi, additional, Brandi, Giovanni, additional, Li, Jin, additional, Chen, Ming-Huang, additional, Kang, Jung Hun, additional, Abdalla, Kathia Cristina, additional, Wysocki, Piotr Jan, additional, Couto, Nuno, additional, Anderson, Bailey, additional, Elsayed, Hamdy, additional, and Mantry, Parvez, additional

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results